Table 1.
Patients demography and clinical/pathological characteristics
| Variables | Treated with BCLT | Untreated with BCLT | P value |
|---|---|---|---|
| Patients, (N) | 51 | 39 | |
| Age (yr) | 67.5 ± 5.5 | 65.2 ± 7.9 | 0.0039a |
| PSA at biopsy (ng/ml) | 5.7 ± 5.1 | 6.4 ± 4.8 | 0.107a |
| Gleason score at biopsy | |||
| ≤6 | 29/51 (56.9%) | 20/39 (51.3%) | 0.753b |
| 7 | 19/51 (37.2) | 17/39 (43.6%) | 0.691b |
| 8–10 | 3/51 (5.9%) | 2/39 (5.1%) | 0.764b |
| Gleason score at radical prostatectomy | |||
| ≤6 | NA | 17/39 (43.6%) | |
| 7 | NA | 19/39 (48.8%) | |
| 8–10 | NA | 3/39 (7.7%) | |
| Pathological stage (TNM 2002) | |||
| pT2 | 14/51 (27.4%) | 16/39 (41.0%) | 0.258b |
| pT3 | 34/51 (66.7) | 20/39 (51.3%) | 0.207b |
| pT4 | 3/51 (5.9%) | 3/39 (7.7%) | 0.931b |
NA, Not assessable.
a
Unpaired Student's t test.
b
χ2 test.